All In MedTech

Device Trial Radar · NCT07911930

LacriFill Canalicular Occlusion for Dry Eye After LASIK

Impact of LacriFill Lacrimal Occlusion on Post-LASIK Dry Eye Symptoms, Ocular Surface Recovery, and Patient-Reported Visual Quality

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Dec 9, 2026

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Mann Eye InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Sengi
First posted
Nov 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a single-site, prospective, randomized (2:1) controlled study of subjects aged 18-39 who are candidates for bilateral LASIK and have dry eye symptoms (OSDI ≥13). The LacriFill group (n=50) receives bilateral lower canalicular LacriFill placement within 7 days prior to surgery plus standard postoperative care; the control group (n=25) receives standard postoperative care only. The primary outcome is the change in Ocular Surface Disease Index (OSDI) score from baseline to 3 months after bilateral LASIK.

Conditions

  • Dry Eye Syndrome

Interventions

  • LacriFill Canalicular FillerDevice

    LacriFill, a crosslinked hyaluronic acid-based bioresorbable gel, instilled for bilateral lower canalicular occlusion within 7 days prior to LASIK surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Ocular Surface Disease Index (OSDI) scoreTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mann Eye Institute

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.